Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.00005 (-33.33%)
At close: Nov 9, 2026
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $167.53 thousand as of November 10, 2026. It is the 51,040th most valuable company in the world and the 7,150th biggest in the United States. Its market cap has decreased by 86.22% in one year.
Market Cap
167.53K
Enterprise Value
1.07M
Revenue
236.56K
Global Rank
Country Rank
#7,150 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 167.53K, a decrease of -99.15%. That is a compound annual growth rate of -32.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 167.53K | -79.05% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 411.51K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 337.23K |
| Nextel Medical | 263.46K |
| RegeneRx Biopharmaceuticals | 260.99K |
| CERo Therapeutics Holdings | 258.13K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 192.58K |